CN1110490C - 磺酰胺取代的稠合七元环化合物,它们作为药物的用途以及含有它们的药物制剂 - Google Patents

磺酰胺取代的稠合七元环化合物,它们作为药物的用途以及含有它们的药物制剂 Download PDF

Info

Publication number
CN1110490C
CN1110490C CN98105329A CN98105329A CN1110490C CN 1110490 C CN1110490 C CN 1110490C CN 98105329 A CN98105329 A CN 98105329A CN 98105329 A CN98105329 A CN 98105329A CN 1110490 C CN1110490 C CN 1110490C
Authority
CN
China
Prior art keywords
formula
compound
physiology
alkyl
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98105329A
Other languages
English (en)
Chinese (zh)
Other versions
CN1193017A (zh
Inventor
J·布兰道尔
H·J·朗
U·格拉赫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CN1193017A publication Critical patent/CN1193017A/zh
Application granted granted Critical
Publication of CN1110490C publication Critical patent/CN1110490C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
CN98105329A 1997-02-26 1998-02-25 磺酰胺取代的稠合七元环化合物,它们作为药物的用途以及含有它们的药物制剂 Expired - Fee Related CN1110490C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19707656.4 1997-02-26
DE19707656A DE19707656A1 (de) 1997-02-26 1997-02-26 Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
CN1193017A CN1193017A (zh) 1998-09-16
CN1110490C true CN1110490C (zh) 2003-06-04

Family

ID=7821518

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98105329A Expired - Fee Related CN1110490C (zh) 1997-02-26 1998-02-25 磺酰胺取代的稠合七元环化合物,它们作为药物的用途以及含有它们的药物制剂

Country Status (25)

Country Link
EP (1) EP0861836B1 (es)
JP (1) JP4171097B2 (es)
KR (1) KR19980071625A (es)
CN (1) CN1110490C (es)
AR (1) AR011163A1 (es)
AT (1) ATE286039T1 (es)
AU (1) AU737461B2 (es)
BR (1) BR9800207A (es)
CA (1) CA2230349A1 (es)
CZ (1) CZ53998A3 (es)
DE (2) DE19707656A1 (es)
ES (1) ES2234044T3 (es)
HR (1) HRP980098A2 (es)
HU (1) HUP9800395A3 (es)
ID (1) ID19931A (es)
IL (1) IL123454A0 (es)
MX (1) MX9801516A (es)
NO (1) NO980785L (es)
NZ (1) NZ329838A (es)
PL (1) PL325045A1 (es)
RU (1) RU2223264C2 (es)
SK (1) SK283312B6 (es)
TR (1) TR199800301A2 (es)
TW (1) TW452574B (es)
ZA (1) ZA981562B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7384937B2 (en) 2002-11-06 2008-06-10 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
US20120309796A1 (en) * 2011-06-06 2012-12-06 Fariborz Firooznia Benzocycloheptene acetic acids
RU2538962C1 (ru) * 2013-11-19 2015-01-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Противогрибковые соединения на основе производных 3,5,8-триоксабицикло[5.1.0]октана

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
WO1995014470A1 (en) * 1993-11-22 1995-06-01 Merck & Co., Inc. Methods of treating cardiac arrhythmia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
WO1995014470A1 (en) * 1993-11-22 1995-06-01 Merck & Co., Inc. Methods of treating cardiac arrhythmia

Also Published As

Publication number Publication date
BR9800207A (pt) 1999-05-18
NO980785D0 (no) 1998-02-25
CN1193017A (zh) 1998-09-16
ZA981562B (en) 1998-08-26
CA2230349A1 (en) 1998-08-26
ATE286039T1 (de) 2005-01-15
TR199800301A2 (xx) 1998-09-21
JPH10287641A (ja) 1998-10-27
AU5633398A (en) 1998-09-03
SK283312B6 (sk) 2003-05-02
ID19931A (id) 1998-08-27
DE59812423D1 (de) 2005-02-03
MX9801516A (es) 1998-11-30
AR011163A1 (es) 2000-08-02
HUP9800395A2 (hu) 2001-04-28
SK23998A3 (en) 1998-09-09
EP0861836B1 (de) 2004-12-29
RU2223264C2 (ru) 2004-02-10
HRP980098A2 (en) 1998-12-31
DE19707656A1 (de) 1998-08-27
HUP9800395A3 (en) 2002-04-29
IL123454A0 (en) 1998-09-24
NO980785L (no) 1998-08-27
PL325045A1 (en) 1998-08-31
JP4171097B2 (ja) 2008-10-22
AU737461B2 (en) 2001-08-23
KR19980071625A (ko) 1998-10-26
EP0861836A1 (de) 1998-09-02
CZ53998A3 (cs) 1998-09-16
TW452574B (en) 2001-09-01
HU9800395D0 (en) 1998-04-28
ES2234044T3 (es) 2005-06-16
NZ329838A (en) 1999-07-29

Similar Documents

Publication Publication Date Title
WO2007105766A1 (ja) グルココルチコイド受容体結合活性を有する新規１，２，３，４－テトラヒドロキノキサリン誘導体
TW201000460A (en) Amide compound
WO2006012227A2 (en) Amido compounds and their use as pharmaceuticals
KR101475168B1 (ko) 암 치료용 신규 ｎ-하이드록시-벤즈아마이드
CN1110490C (zh) 磺酰胺取代的稠合七元环化合物,它们作为药物的用途以及含有它们的药物制剂
EP0906911B1 (de) Sulfonamid-substituierte Chromane (K+Kanal-Blocker), Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CN1194982A (zh) 磺酰氨取代的苯并二氢吡喃、其制备方法、它们作为药物或诊断剂的用途和含有它们的药物
JP4331809B2 (ja) スルホンアミド置換−５員縮合環化合物、医薬としてのその使用およびそれを含有する医薬製剤
JP4430749B2 (ja) スルホンアミド置換ベンゾピラン誘導体、その製造法、医薬としてのその使用およびそれを含有する医薬製剤
NO308948B1 (no) Tetraliner som bærer en fenylsubstituent pÕ den aromatiske ringen, farmasøytisk preparat inneholdende slike forbindelser, deres anvendelse for behandling av epilepsi, slag og hjerne- eller spinaltrauma, og fremgangsmÕte for deres fremstilling
KR20060096038A (ko) 3-아자비시클로〔3.1.0〕헥산 유도체의 제조법
US6069257A (en) Process for the production of tetrazolylbenzopyrans
EP2417111B1 (fr) Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique
US6333349B1 (en) Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
HU224029B1 (hu) Szulfonamiddal szubsztituált krománok, eljárás előállításukra, alkalmazásuk gyógyszerként, valamint ilyen vegyületeket tartalmazó gyógyászati készítmények
JPS6115874A (ja) 抗高血圧剤及びコレシストキニンきつ抗物質として有用なベンゼン環の縮合したラクタム
KR19980071212A (ko) 설폰아미드 치환된 화합물, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제
EP3498273A1 (en) Pharmaceutical composition for modulating the response of a gaba-a receptor
MXPA98001121A (es) Compuestos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como medicamento que los contiene
MXPA98009370A (es) Compuestos condensados con anillo de 5 miembros,sustituidos con sulfonamida, su utilizacion comomedicamentos, asi como preparados farmaceuticosque los contienen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1015787

Country of ref document: HK